Andrew Young, MD PhD

Hometown: Bethesda, Maryland
Medical School: Washington University School of Medicine
Residency: Washington University School of Medicine
Research/Academic Interests: Hematological malignancies, clonal evolution
Bio: I am an amateur wood splitter, birdwatcher, father.

Selected Publications/Abstracts

  • *Wong TN,* Ramsingh G, *Young AL, Miller CA, Touma W, Welch JS, Lamprecht T, Shen D, Hundal J, Fulton RS, Heath S, Baty JD, Ding L, Mardis ER, Westervelt P, DiPersio JF, Walter MJ, Graubert TA, Ley TJ, Druley TE, Link DC, Wilson RK. The Role of Early TP53 Mutations in the Evolution of Therapy-Related AML. Nature 518, 552-555 (2015). PMCID: PMC4403236 ( *denotes equal contribution).
  • Young AL, Wong TN, Hughes AEO, Heath S, Ley TJ, Link DC, Druley TE. Quantifying Ultra-Rare Pre-Leukemic Clones via Targeted Error-Corrected Sequencing. Leukemia 29, 1608-1611 (2015). PMCID: PMC4497921.
  • Young AL, Challen GA, Birmann BM, Druley TE. Clonal Hematopoiesis Harboring AML-Associated Mutations is Ubiquitous in Healthy Adults. Nat Commun 7, 12484 (2016). PMCID: PMC4996934.
  • Young AL, Tong RS, Birmann BM, Druley TE. Clonal Haematopoiesis and Risk of Acute Myeloid Leukemia. Haematologica. 140(12), 2410-2417 (2019). PMCID: PMC6959179.